Patents by Inventor Ralph Stone

Ralph Stone has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20180105415
    Abstract: A fuel nozzle is provided including a fuel spout configured to dispense fuel and an enhanced tip disposed at a dispensing end of the fuel spout, the enhanced tip comprising a generally smooth exposed surface configured to limit abrasion of materials contacted by the dispensing end of the fuel spout.
    Type: Application
    Filed: October 16, 2017
    Publication date: April 19, 2018
    Inventors: Jesse Devon Juday, Thor Michael Smith, William Ralph Stone, JR.
  • Publication number: 20070059381
    Abstract: The present invention is directed to methods for enhancing current treatment regimens for age-related macular degeneration (AMD). The methods of the invention include intraocular delivery of AMD compositions along with antioxidant compositions. Alternatively, the methods of the invention include a daily regimen of ocular vitamin consumption in conjunction with other treatment methods for AMD.
    Type: Application
    Filed: June 18, 2004
    Publication date: March 15, 2007
    Inventors: Ronnie Barker, John Lang, Ralph Stone
  • Patent number: 5817277
    Abstract: The present invention covers a method for disinfecting a contact lens including contacting the lens with an isotonic aqueous solution comprising 0.6 to 2 weight percent tromethamine (preferably 0.8 to 1.5 percent) for a time sufficient to disinfect the lens. Other aspects include adding to the solution from 0.01 to 1 weight percent chelating agent (preferably disodium EDTA) and/or additional microbicide.
    Type: Grant
    Filed: October 11, 1996
    Date of Patent: October 6, 1998
    Assignee: Allergan
    Inventors: Mary Mowrey-McKee, Kenneth Bliznik, Ralph Stone
  • Patent number: 5756045
    Abstract: The present invention covers a method for disinfecting a contact lens including contacting the lens with an isotonic aqueous solution comprising 0.6 to 2 weight percent tromethamine (preferably 0.8 to 1.5 percent) for a time sufficient to disinfect the lens. Other aspects include adding to the solution from 0.01 to 1 weight percent chelating agent (preferably disodium EDTA) and/or additional microbicide.
    Type: Grant
    Filed: November 22, 1996
    Date of Patent: May 26, 1998
    Assignee: Allergan
    Inventors: Mary Mowrey-McKee, Kenneth Bliznik, Ralph Stone
  • Patent number: 5593637
    Abstract: The present invention covers a method for disinfecting a contact lens including contacting the lens with an isotonic aqueous solution comprising 0.6 to 2 weight percent tromethamine (preferably 0.8 to 1.5 percent) for a time sufficient to disinfect the lens. Other aspects include adding to the solution from 0.01 to 1 weight percent chelating agent (preferably disodium EDTA) and/or additional microbicide.
    Type: Grant
    Filed: January 26, 1996
    Date of Patent: January 14, 1997
    Assignee: Allergan
    Inventors: Mary Mowrey-McKee, Kenneth Bliznik, Ralph Stone
  • Patent number: 5500186
    Abstract: The present invention covers a method for disinfecting a contact lens including contacting the lens with an isotonic aqueous solution comprising 0.6 to 2 weight percent tromethamine (preferably 0.8 to 1.5 percent) for a time sufficient to disinfect the lens. Other aspects include adding to the solution from 0.01 to 1 weight percent chelating agent (preferably disodium EDTA) and/or additional microbicide.
    Type: Grant
    Filed: March 10, 1995
    Date of Patent: March 19, 1996
    Assignee: Allergan, Inc.
    Inventors: Mary Mowrey-McKee, Kenneth Bliznik, Ralph Stone
  • Patent number: 5422073
    Abstract: The present invention covers a method for disinfecting a contact lens including contacting the lens with an isotonic aqueous solution comprising 0.6 to 2 weight percent tromethamine (preferably 0.8 to 1.5 percent) for a time sufficient to disinfect the lens. Other aspects include adding to the solution from 0.01 to 1 weight percent chelating agent (preferably disodium EDTA) and/or additional microbicide.
    Type: Grant
    Filed: June 17, 1993
    Date of Patent: June 6, 1995
    Assignee: Allergan, Inc.
    Inventors: Mary Mowrey-McKee, Kenneth Bliznik, Ralph Stone